ASO Author Reflections: Sentinel Node Biopsy—Retirement Will Have to Wait

This is a preview of subscription content, log in to check access.


  1. 1.

    Morton DL, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

    CAS  PubMed  Google Scholar 

  2. 2.

    Zagarella S. Sentinel lymph node biopsy still provides no benefits for patients with melanoma. Am J Dermatopathol. 2020;42(7):481–3.

    PubMed  Google Scholar 

  3. 3.

    Gershenwald JE, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer, eighth-edition cancer staging manual. CA Cancer J Clin. 2017;67:472–92.

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Fonseca IB, et al. Sentinel node status is the most important prognostic information for clinical stage IIB and IIC melanoma patients. Ann Surg Oncol. 2020.

  5. 5.

    Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173–80.

    PubMed  PubMed Central  Google Scholar 

Download references


We acknowledge Prof. Francisco Belfort, MD, PhD, for his valuable insights on these reflections.

Author information



Corresponding author

Correspondence to Eduardo Bertolli MD, PhD.

Ethics declarations


The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bertolli, E., Calsavara, V.F. ASO Author Reflections: Sentinel Node Biopsy—Retirement Will Have to Wait. Ann Surg Oncol 27, 4141–4142 (2020).

Download citation